The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction - PubMed (original) (raw)
Review
The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction
Subhash C Pandey. Pharmacol Ther. 2004 Oct.
Abstract
The gene transcription factor cyclic adenosine monophosphate (cAMP)-responsive element binding (CREB) protein is a nuclear protein that regulates synaptic plasticity via modulating the expression of several (cAMP)-inducible genes. Alcohol addiction is a complex psychiatric disorder and is characterized by a compulsive and uncontrolled pattern of alcohol drinking by an individual in spite of the adverse consequences of its abuse. Ethanol produces both euphoric (reward and reinforcing) and dysphoric (negative withdrawal reactions) effects and these are most likely involved in the initiation and maintenance of alcohol use and abuse. Several neurotransmitter systems in the brain might be involved in the effects of alcohol but the exact molecular mechanisms of both the positive and negative affective states of alcohol abuse are still unclear. Recent research in molecular neurosciences using animal models have identified the role of extended amygdaloid (shell structures of nucleus accumbens [NAc] and central and medial amygdaloid nuclei) CREB signaling in positive and negative affective states of alcohol drinking behaviors. This review article highlights the current findings on the role of nucleus accumbal and amygdaloid CREB signaling in behavioral consequences of alcohol use and abuse.
Similar articles
- Involvement of the cyclic AMP-responsive element binding protein gene transcription factor in genetic preference for alcohol drinking behavior.
Pandey SC, Mittal N, Lumeng L, Li TK. Pandey SC, et al. Alcohol Clin Exp Res. 1999 Sep;23(9):1425-34. Alcohol Clin Exp Res. 1999. PMID: 10512306 - Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene.
Pandey SC. Pandey SC. Trends Pharmacol Sci. 2003 Sep;24(9):456-60. doi: 10.1016/S0165-6147(03)00226-8. Trends Pharmacol Sci. 2003. PMID: 12967770 Review. - The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism.
Wand G. Wand G. J Clin Invest. 2005 Oct;115(10):2697-9. doi: 10.1172/JCI26436. J Clin Invest. 2005. PMID: 16200206 Free PMC article. Review.
Cited by
- Ethanol-BDNF interactions: still more questions than answers.
Davis MI. Davis MI. Pharmacol Ther. 2008 Apr;118(1):36-57. doi: 10.1016/j.pharmthera.2008.01.003. Epub 2008 Feb 2. Pharmacol Ther. 2008. PMID: 18394710 Free PMC article. Review. - The Potential Role of Amygdaloid MicroRNA-494 in Alcohol-Induced Anxiolysis.
Teppen TL, Krishnan HR, Zhang H, Sakharkar AJ, Pandey SC. Teppen TL, et al. Biol Psychiatry. 2016 Nov 1;80(9):711-719. doi: 10.1016/j.biopsych.2015.10.028. Epub 2015 Nov 26. Biol Psychiatry. 2016. PMID: 26786313 Free PMC article. - CaMKII inhibition in the prefrontal cortex specifically increases the positive reinforcing effects of sweetened alcohol in C57BL/6J mice.
Faccidomo S, Reid GT, Agoglia AE, Ademola SA, Hodge CW. Faccidomo S, et al. Behav Brain Res. 2016 Feb 1;298(Pt B):286-90. doi: 10.1016/j.bbr.2015.11.018. Epub 2015 Nov 19. Behav Brain Res. 2016. PMID: 26608538 Free PMC article. - Epigenetics-beyond the genome in alcoholism.
Starkman BG, Sakharkar AJ, Pandey SC. Starkman BG, et al. Alcohol Res. 2012;34(3):293-305. Alcohol Res. 2012. PMID: 23134045 Free PMC article. - Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.
Namba MD, Leyrer-Jackson JM, Nagy EK, Olive MF, Neisewander JL. Namba MD, et al. Front Neurosci. 2021 Apr 15;15:650785. doi: 10.3389/fnins.2021.650785. eCollection 2021. Front Neurosci. 2021. PMID: 33935636 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical